EverydayHealthLogo
DB

Dr. Daniel Bernstein, MD

Palo Alto, CA

41 Years of Experience

Accepting patients

    Who is Dr. Bernstein, Pediatric Cardiologist in Palo Alto, CA?

    Dr. Daniel Bernstein, MD is a Pediatric Cardiologist, who primarily practices in Palo Alto, CA. He has been practicing for over 41 years and is board certified. Dr. Bernstein graduated from New York University School of Medicine and completed his residency at Univ Ca Sf Sch Of Med, Pediatrics; Montefiore M C-H&l Moses Div, Pediatrics. Dr. Bernstein is fluent in English, Chinese, Korean, Spanish, Tagalog, and Vietnamese, and is currently seeing new patients. Dr. Bernstein’s practice accepts Kaiser Permanente, Medicare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Bernstein’s office at (650) 497-8000.

    What are Areas of Expertise for Dr. Bernstein?

    Dr. Daniel Bernstein, MD is a highly-rated, board-certified Pediatric Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Bernstein empowers patients to confidently navigate their health journey, specializing in Heart Failure, Transplant Medicine-Heart, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Bernstein is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Bernstein go to medical school and complete their residency?

    • Residency: Univ Ca Sf Sch Of Med, Pediatrics; Montefiore M C-H&l Moses Div, Pediatrics | Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore) Program

    • Medical School: New York Univ Sch of Med, New York Ny | New York University School of Medicine

    Is Dr. Bernstein board certified as a Pediatric Cardiologist?

    Yes, Dr. Daniel Bernstein, MD is board certified by the American Board of Pediatrics

    What languages does Dr. Bernstein speak?

    Dr. Bernstein and their clinical team can communicate with patients in the following languages:

    • Chinese

    • English

    • Korean

    • Spanish

    • Tagalog

    • Vietnamese

    What conditions does a Pediatric Cardiologist like Dr. Bernstein typically treat?

    As a Pediatric Cardiologist, Dr. Bernstein diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Bernstein. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.

    Also known as:

    • Tetralogy of Fallot
    • Discordant Ventriculoarterial Connection
    • Congenital Heart Defects
    • Critical congenital heart disease
    • TOF
    • Blue Baby Syndrome
    • Complex Heart Defect
    • Transposition of the Great Arteries
    • Congenital Heart Anomaly
    • Heart Artery Misconnection

    ICD-10 Codes:

    • Q213: Tetralogy of Fallot
    • Q203: Discordant ventriculoarterial connection

    Also known as:

    • Having a Heart Transplant
    • Heart Transplantation
    • Cardiac transplant
    • Heart replacement surgery
    • Post-heart transplant

    ICD-10 Codes:

    • Z941: Heart transplant status

    What procedures does a Pediatric Cardiologist like Dr. Bernstein typically perform?

    As a Pediatric Cardiologist, procedures performed by Dr. Daniel Bernstein may include:

    Please contact Dr. Bernstein's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Bernstein accept my insurance?

    Dr. Bernstein accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Bernstein accept in Palo Alto, CA?

    Dr. Bernstein in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Shield of California

    • California Water Service Group

    • Community Health Network of Washington

    • CVS Health (formerly Aetna)

    • Kaiser Permanente

    • Molina Healthcare

    • Santa Cruz County

    • State of California

    • UnitedHealth Group

    View All Insurances

    Where is Dr. Bernstein's office located?

    Dr. Daniel Bernstein's Primary Practice

    725 Welch Rd

    Palo Alto, CA 94304

    (650) 497-8000

    Get Directions

    Recognitions

    Publications

    Multi-institutiol Study of Outcomes After Pediatric Heart Transplantation

    , 2014

    Orthotopic heart transplantation in two infants with histiocytoid cardiomyopathy

    , 2013

    Deletion of the beta 2-adrenergic receptor prevents the development of cardiomyopathy in mice

    , 2013

    Lower socioeconomic status is associated with worse outcomes after both listing

    , 2013

    Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy

    , 2013

    Physiologic and molecular characterization of a murine model of right ventricular volume overload.

    , 2013

    Abdomil complaints as a common first presentation of heart failure

    , 2013

    Intermediate-term outcomes after combined heart

    , 2013

    Sacrificial layer technique for axial force post assay of immature cardiomyocytes

    , 2013

    Brg1 governs distinct pathways to direct multiple

    , 2013

    Loss of adenomatous poliposis coli

    , 2012

    Loss of Adenomatous Poliposis Coli

    , 2012

    Rel function and genetic polymorphisms in pediatric heart transplant recipients

    , 2012

    Outcomes of Children Following a First Hospitalization for Dilated Cardiomyopathy

    , 2012

    Dymic microR expression during the transition from right ventricular hypertrophy to failure

    , 2012

    Use of the Impella 5.0 as a bridge from ECMO to implantation of the HeartMate II left ventricular

    , 2012

    In Vivo Functiol and Transcriptiol Profiling of Bone Marrow Stem Cells After Transplantation Into

    , 2012

    Pharmacological inhibition of beta IIPKC is cardioprotective in late-stage hypertrophy

    , 2011

    beta 2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell

    , 2011

    Cardiac pressure overload hypertrophy is differentially regulated by beta

    , 2011

    Familial Cardiac Valvulopathy Due to Filamin A Mutation

    , 2011

    Gene Polymorphisms Impact the Risk of Rejection With Hemodymic Compromise: A Multicenter Study

    , 2011

    Calibrated micropost arrays for biomechanical characterisation of cardiomyocytes

    , 2011

    Clinical usefulness of a novel C1q

    , 2011

    NEW DIRECTIONS IN BASIC RESEARCH IN HYPERTROPHY AND HEART FAILURE

    , 2011

    THE ROLE OF ?-ADRENERGIC RECEPTORS IN HEART FAILURE

    , 2011

    Association of genetic polymorphisms

    , 2010

    Interagency Registry for Mechanically Assisted Circulatory Support

    , 2010

    Behcet's disease and heart transplantation: A word of caution

    , 2010

    Endogenous regulation of cardiovascular function by apelin-APJ

    , 2009

    Association of Left Ventricular Dilation at Listing for Heart Transplant With Postlisting

    , 2009

    Hypercholesterolemia impairs exercise capacity in mice

    , 2009

    Genotypic Variation and Phenotypic Characterization of Granzyme B Gene Polymorphisms

    , 2009

    Molecular and physiological characterization of RV remodeling in a murine model of pulmory stenosis

    , 2008

    Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation

    , 2008

    Prevention of pediatric graft corory artery disease: Atorvastatin

    , 2008

    Microsystems for biomechanical measurements

    , 2008

    Gene expression profiling distinguishes a molecular sigture

    , 2007

    Indications for heart transplantation in pediatric heart disease

    , 2007

    Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic

    , 2006

    Pediatric cardiac transplantation.

    , 2006

    Outcome of listing for cardiac transplantation for failed Fontan - A multi-institutiol study

    , 2006

    Neurologic events in neotes treated surgically for congenital heart disease

    , 2006

    Differential cardiotoxic/cardioprotective effects

    , 2006

    Ten- and 20-year survivors of pediatric orthotopic heart transplantation

    , 2006

    Effect of targeted deletions of beta(1)-

    , 2006

    Differential cardioprotective/cardiotoxic effects mediated by ss-adrenergic receptor subtypes

    , 2005

    Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmory hypertension

    , 2005

    Induction therapy for pediatric and adult heart transplantation

    , 2005

    Experience of percutaneous corory intervention

    , 2005

    The role of beta-adrenergic receptor sigling in cardioprotection.

    , 2005

    The role of beta-adrenergic receptor sigling in cardioprotection

    , 2005

    Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients

    , 2005

    The endogenous peptide apelin potently improves cardiac contractility

    , 2005

    Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic

    , 2004

    Intertiol society for heart and lung transplantation

    , 2004

    The mouse as a model of cardiovascular adaptations to microgravity

    , 2004

    Microarray alysis of gene expression after transverse aortic constriction in mice

    , 2004

    Linearity versus cross-talk

    , 2004

    Identifying cardiac transplant rejection in children

    , 2004

    Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience

    , 2004

    Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation

    , 2003

    Exercise assessment of transgenic models of human cardiovascular disease

    , 2003

    Efficacy and safety of atorvastatin after pediatric heart transplantation

    , 2002

    Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice

    , 2002

    Cardiovascular and metabolic alterations in mice lacking beta 1- and beta 2-adrenergic receptors

    , 2002

    Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients

    , 2002

    Infant heart transplantation at Stanford: Growth and neurodevelopmental outcome

    , 2002

    Survey of current practices in use of amiodarone

    , 2001

    L-Arginine enhances aerobic exercise capacity in association with augmented nitric oxide production

    , 2001

    Efficacy and safety of atorvastatin after pediatric cardiac transplantation.

    , 2001

    Outcome while awaiting heart transplantation in children

    , 2000

    Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.

    , 2000

    Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart

    , 2000

    The use of advanced-age donor hearts adversely affects survival in pediatric heart transplantation.

    , 1999

    Heart transplantation in children

    , 1999

    QT dispersion predicts ventricular arrhythmia

    , 1999

    Abnormal regulation of the sympathetic nervous system in alpha

    , 1999

    Targeted disruption of the beta 2 adrenergic receptor gene

    , 1999

    Cardiovascular and metabolic alterations in mice lacking both beta 1-and beta 2

    , 1999

    American Pediatric Society Society for Pediatric Research code of responsible conduct of research

    , 1999

    Phospholamban deficiency does not compromise exercise capacity

    , 1999

    Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training

    , 1999

    Limb blood flow during exercise is dependent on nitric oxide

    , 1998

    Alterations in dymic heart rate control in the beta(1)-adrenergic receptor knockout mouse

    , 1998

    Elective transplant pneumonectomy

    , 1998

    The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2

    , 1998

    Survival and risk factors for death after cardiac transplantation in infants - A multi

    , 1997

    Predicting outcome after listing for heart transplantation in children

    , 1997

    Cardiovascular indexes in the mouse at rest and with exercise

    , 1997

    Developmental and afterload stress regulation of heat shock proteins in the ovine myocardium

    , 1997

    Cardiovascular regulation in mice lacking alpha(2)-adrenergic receptor subtypes b and c

    , 1996

    Targeted disruption of the mouse beta 1-adrenergic receptor gene

    , 1996

    CARDIAC TRANSPLANTATION FOR HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH SENGERS-SYNDROME

    , 1995

    COLCHICINE AND CYTOCHALASIN-B ENHANCE CYCLIC-AMP ACCUMULATION VIA POSTRECEPTOR ACTIONS

    , 1995

    ARTERIAL SWITCH AND RESECTION OF HEPATIC HEMANGIOENDOTHELIOMA

    , 1995

    Pediatric cardiac transplantation. The Stanford experience.

    , 1994

    SUCCESSFUL THROMBOLYSIS OF A THROMBOSED ST-JUDE MEDICAL MITRAL PROSTHESIS IN A 2-MONTH-OLD INFANT

    , 1994

    NEOPLASTIC DISORDERS AFTER PEDIATRIC HEART-TRANSPLANTATION

    , 1993

    Neoplastic disorders after pediatric heart transplantation.

    , 1993

    HEART-TRANSPLANTATION IN INFANCY

    , 1993

    PRIMARY STRUCTURE OF THE MOUSE BETA(1)-ADRENERGIC RECEPTOR GENE

    , 1993

    Update on cardiac transplantation in infants and children.

    , 1993

    ALTERATION IN GS-MEDIATED SIGL TRANSDUCTION IN S49 LYMPHOMA

    , 1993

    TRANSCRIPTIOL REGULATION OF LEFT-VENTRICULAR BETA-ADRENERGIC RECEPTORS DURING CHRONIC HYPOXIA

    , 1992

    CURRENT APPROACH TO HYPOPLASTIC LEFT HEART SYNDROME - PALLIATION, TRANSPLANTATION, OR BOTH

    , 1992

    CARDIAC GROWTH AFTER PEDIATRIC HEART-TRANSPLANTATION

    , 1992

    DECREASED SERUM INSULIN-LIKE GROWTH FACTOR

    , 1992

    ALTERATIONS IN POSTTAL INTESTIL FUNCTION DURING CHRONIC HYPOXEMIA

    , 1992

    HEART, HEART-LUNG, AND LUNG TRANSPLANTATION IN THE 1ST YEAR OF LIFE

    , 1992

    REGULATION OF ATRIAL AUTONOMIC RECEPTORS IN EXPERIMENTAL CYANOTIC HEART-DISEASE

    , 1991

    PEDIATRIC HEART-TRANSPLANTATION AT STANFORD - RESULTS OF A 15-YEAR EXPERIENCE

    , 1991

    EBSTEINS-ANOMALY APPEARING IN THE NEOTE - A NEW SURGICAL APPROACH

    , 1991

    COMPARATIVE CIRCULATORY EFFECTS OF ISOPROTERENOL AND DOPAMINE IN LAMBS WITH EXPERIMENTAL CYANOTIC

    , 1991

    Pediatric heart transplantation.

    , 1990

    DIFFERENTIAL REGULATION OF RIGHT AND LEFT-VENTRICULAR BETA

    , 1990

    HEART-TRANSPLANTATION IN CHILDREN

    , 1989

    What is Dr. Bernstein's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Bernstein's National Provider Identifier (NPI) number is 1972527687.

    What common questions do patients ask about Dr. Bernstein?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Bernstein

    What is Dr. Daniel Bernstein's specialty?

    Dr. Bernstein is a Pediatric Cardiologist near Palo Alto, CA.

    What does a Pediatric Cardiologist do?

    A pediatric cardiologist provides comprehensive care for children with cardiovascular issues, offering expertise in diagnosing, treating, and managing heart and blood vessel conditions. This specialist is skilled in selecting, performing, and interpreting structural and functional assessments of the heart and blood vessels, as well as conducting thorough clinical evaluations of cardiovascular diseases in young patients.

    Is this Dr. Daniel Bernstein affiliated with a ranked Castle Connolly Top Hospital?

    No, Bernstein is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Pediatric Cardiologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Pediatric Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Daniel Bernstein accepting new patients in Palo Alto, CA?

    Yes, Dr. Daniel Bernstein is accepting new patients at this time.

    Does Dr. Daniel Bernstein offer online booking?

    Please contact Dr. Bernstein's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Daniel Bernstein?

    Please contact Dr. Bernstein's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Daniel Bernstein have?

    Dr. Daniel Bernstein is certified by the American Board of Pediatrics.

    Other Pediatric Cardiologist Near Palo Alto, CA

    AB

    Pediatric Cardiologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    SP

    Pediatric Cardiologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    DM

    Pediatric Cardiologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    See All Specialists

    Doctors by Category

    Specialists